A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032)

NCT07646860 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

BIOLOGICAL: Sotatercept

Sponsor

Merck Sharp & Dohme LLC